In Vivo generation of anti-CD19 CAR-T cells for the treatment of B-cell mediated autoimmune diseases

作者
Eli Pasackow,Camille F Khairallah,Joshua Ferrell,Adrianna Graziano,Mengmeng Zheng,Jennifer Tian,Daniel Kong,Jamie Yuan,Srujan Kumar Gandham,Shreya Mukherji,Suzeeta Bhandari,Pavel Makarov,Nikita Prajapati,Venus Sahu,Aidan O'Willey,Sanmit Adhikari,William Brinton,Mansi Deshmukh,Clarissa Esmeralda Halim,Elizabeth Belcher
出处
期刊:Blood [Elsevier BV]
卷期号:146 (Supplement 1): 4106-4106 被引量:6
标识
DOI:10.1182/blood-2025-4106
摘要

Abstract Emerging clinical data demonstrate the transformative potential of B cell-depleting CAR-T therapies for patients with autoimmune diseases. However, despite their promise, the broad clinical deployment of ex vivo CAR-T therapies remains limited by several key challenges including manufacturing complexity, high cost, the need for lymphodepleting chemotherapy, and safety risks related to cytokine release syndrome. In addition, the persistence of administered CAR-T cells can lead to prolonged B cell aplasia, leaving patients immunocompromised long after the clearance of pathogenic B cell clones. To overcome these limitations while preserving efficacy, we have developed a novel, transient in vivo T cell engineering platform that utilizes our targeted lipid nanoparticle (tLNP) to deliver mRNA encoding an anti-CD19 CAR specifically to cytotoxic CD8+ T cells. This targeted delivery system drives rapid and precise in vivo engineering of T cells without the need for ex vivo manipulation or pre-conditioning. The resulting CAR-T cells exhibit potent cytolytic activity and high specificity across in vitro assays and preclinical in vivo models. Following a single two-dose treatment cycle in studies of CD34+ humanized mice and non-human primates, we observe potent and durable B cell depletion from the periphery and B cell rich tissues, including the spleen, bone marrow and lymph nodes at doses as low as 0.3 mg/kg. Importantly, this depletion encompasses differentiated B cell populations while sparing early progenitors. In the weeks after the transient depletion phase, B cell recovery is observed, marked by the emergence of a predominantly naïve B cell compartment. This profile is consistent with a clinically relevant immune reset, thought to be a benchmark for successful treatment in autoimmune patients. Together, these data demonstrate that transient, in vivo-generated CAR-T cells, enabled by our proprietary tLNP platform, can recapitulate the benefits of ex vivo CAR-T therapies while minimizing associated risks. This approach offers a scalable, repeatable, and safer alternative to ex vivo CAR T therapies in autoimmune disease, with broad applicability across diverse patient populations.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
杀死周一完成签到,获得积分10
1秒前
tina酱完成签到 ,获得积分10
3秒前
zhangyiyang完成签到 ,获得积分10
3秒前
隐形骁完成签到,获得积分10
3秒前
4秒前
16601107082发布了新的文献求助10
5秒前
liuchang完成签到 ,获得积分10
5秒前
22336完成签到,获得积分0
5秒前
Lemenchichi完成签到,获得积分10
5秒前
老实的鑫磊完成签到,获得积分20
6秒前
会过期的凤梨完成签到 ,获得积分10
7秒前
hahaha完成签到 ,获得积分10
7秒前
wailwq完成签到 ,获得积分10
8秒前
8秒前
8秒前
怕黑的冰安完成签到,获得积分10
9秒前
大卫戴完成签到 ,获得积分10
9秒前
临天下完成签到,获得积分10
9秒前
小楞楞完成签到,获得积分10
10秒前
tanfor完成签到 ,获得积分10
11秒前
孤星发布了新的文献求助10
11秒前
Matthewwt完成签到,获得积分10
11秒前
hyd完成签到,获得积分10
12秒前
123完成签到,获得积分10
12秒前
大个的应助被16601107082采纳,获得10
13秒前
orixero的应助被仔仔在采纳,获得10
14秒前
123完成签到 ,获得积分10
15秒前
甜美的盼晴完成签到 ,获得积分10
15秒前
xiuxue424完成签到,获得积分10
15秒前
郑丽琴完成签到 ,获得积分10
16秒前
梦安完成签到 ,获得积分10
16秒前
HHH完成签到 ,获得积分10
16秒前
小龙仔123完成签到 ,获得积分10
16秒前
尼斯湖中的小水怪完成签到 ,获得积分10
17秒前
DearRy完成签到 ,获得积分10
17秒前
邱继鹏完成签到,获得积分10
18秒前
19秒前
十一苗完成签到 ,获得积分10
20秒前
wuda完成签到,获得积分10
20秒前
夏雨完成签到 ,获得积分10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8166570
求助须知:如何正确求助?哪些是违规求助? 9559581
关于积分的说明 21750904
捐赠科研通 7757397
什么是DOI,文献DOI怎么找? 3429170
关于科研通互助平台的介绍 2553530
邀请新用户注册赠送积分活动 2473923